These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37377442)

  • 21. Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV.
    Lokugamage KG; Hage A; de Vries M; Valero-Jimenez AM; Schindewolf C; Dittmann M; Rajsbaum R; Menachery VD
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells.
    Gori Savellini G; Anichini G; Cusi MG
    Virus Res; 2023 Jul; 332():199134. PubMed ID: 37192725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways.
    Deng J; Zheng Y; Zheng SN; Nan ML; Han L; Zhang J; Jin Y; Pan JA; Gao C; Wang PH
    J Med Virol; 2023 Mar; 95(3):e28561. PubMed ID: 36755358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition.
    Pan R; Kindler E; Cao L; Zhou Y; Zhang Z; Liu Q; Ebert N; Züst R; Sun Y; Gorbalenya AE; Perlman S; Thiel V; Chen Y; Guo D
    mBio; 2022 Feb; 13(1):e0366221. PubMed ID: 35073761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes.
    Li Y; Renner DM; Comar CE; Whelan JN; Reyes HM; Cardenas-Diaz FL; Truitt R; Tan LH; Dong B; Alysandratos KD; Huang J; Palmer JN; Adappa ND; Kohanski MA; Kotton DN; Silverman RH; Yang W; Morrisey EE; Cohen NA; Weiss SR
    Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33811184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 NSP12 Protein Is Not an Interferon-β Antagonist.
    Li A; Zhao K; Zhang B; Hua R; Fang Y; Jiang W; Zhang J; Hui L; Zheng Y; Li Y; Zhu C; Wang PH; Peng K; Xia Y
    J Virol; 2021 Aug; 95(17):e0074721. PubMed ID: 34133897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons.
    Czerkies M; Kochańczyk M; Korwek Z; Prus W; Lipniacki T
    J Virol; 2022 Nov; 96(22):e0134122. PubMed ID: 36326278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRL4B E3 ligase recruited by PRPF19 inhibits SARS-CoV-2 infection by targeting ORF6 for ubiquitin-dependent degradation.
    Zhang L; Hao P; Chen X; Lv S; Gao W; Li C; Li Z; Zhang W
    mBio; 2024 Feb; 15(2):e0307123. PubMed ID: 38265236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy.
    Han L; Zheng Y; Deng J; Nan ML; Xiao Y; Zhuang MW; Zhang J; Wang W; Gao C; Wang PH
    J Med Virol; 2022 Nov; 94(11):5174-5188. PubMed ID: 35765167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
    Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
    Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) and Spike (S) Proteins Antagonize Host Type I Interferon Response.
    Zhang Q; Chen Z; Huang C; Sun J; Xue M; Feng T; Pan W; Wang K; Dai J
    Front Cell Infect Microbiol; 2021; 11():766922. PubMed ID: 34950606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.
    Yuen CK; Lam JY; Wong WM; Mak LF; Wang X; Chu H; Cai JP; Jin DY; To KK; Chan JF; Yuen KY; Kok KH
    Emerg Microbes Infect; 2020 Dec; 9(1):1418-1428. PubMed ID: 32529952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein.
    De Angelis M; Anichini G; Palamara AT; Nencioni L; Gori Savellini G
    Virol J; 2023 Oct; 20(1):239. PubMed ID: 37853388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein Suppresses Type I IFN Expression by Impeding HSP70-Dependent Activation of IRF3 Kinase IKKε.
    Wong LR; Ye ZW; Lui PY; Zheng X; Yuan S; Zhu L; Fung SY; Yuen KS; Siu KL; Yeung ML; Cai Z; Woo PC; Yuen KY; Chan CP; Jin DY
    J Immunol; 2020 Sep; 205(6):1564-1579. PubMed ID: 32747502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All hands on deck: SARS-CoV-2 proteins that block early anti-viral interferon responses.
    Setaro AC; Gaglia MM
    Curr Res Virol Sci; 2021; 2():100015. PubMed ID: 34786565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
    Chang CY; Liu HM; Chang MF; Chang SC
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication.
    Miyamoto Y; Itoh Y; Suzuki T; Tanaka T; Sakai Y; Koido M; Hata C; Wang CX; Otani M; Moriishi K; Tachibana T; Kamatani Y; Yoneda Y; Okamoto T; Oka M
    Commun Biol; 2022 May; 5(1):483. PubMed ID: 35590097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options.
    Znaidia M; Demeret C; van der Werf S; Komarova AV
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe Acute Respiratory Syndrome Coronavirus 2 ORF8 Protein Inhibits Type I Interferon Production by Targeting HSP90B1 Signaling.
    Chen J; Lu Z; Yang X; Zhou Y; Gao J; Zhang S; Huang S; Cai J; Yu J; Zhao W; Zhang B
    Front Cell Infect Microbiol; 2022; 12():899546. PubMed ID: 35677655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.